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1. Introduction 
Iron is the fourth most abundant element on Earth and is essential for almost all living 
organisms. However, it is not accessible to cells in every environment. Ferric iron solubility 
is low at physiological pH, and in aerobic environments, ferrous iron is highly toxic. Thus, 
iron is not free but bound to proteins [Clarke et al., 2001; Taylor and Kelly, 2010]. In complex 
organisms, the majority of iron is intracellularly sequestered within heme-compounds or 
iron-containing proteins or is stored in ferritin.  
Extracellular ferric iron is bound to lactoferrin (LF) and transferrin (TF). Lactoferrin is found 
mainly in secretions such as milk, saliva, mucosal secretions, and other secretory fluids. TF 
is the iron transporter that allows cellular iron uptake. Additionally, TF and LF maintain 
Fe3+ in a soluble and stable oxidation state, avoiding the generation of toxic free radicals 
through the Fenton reaction (Fe2+ + H2O2→ Fe3+ OH- + OH), which are deleterious to most 
macromolecules [Clarke et al., 2001; Wandersman and Delepelaire, 2004; Halliwell and 
Gutteridge, 2007; Gkouvatsos et al., 2012].  
1.1. Transferrin and the transferrin receptor: An overview 
TF is mainly found in serum and lymph. It binds two atoms of Fe3+ with high affinity (Ka of 
10-23 M). TF is a single-chain glycoprotein with a molecular mass of approximately 80 kDa 
and two homologous lobes. Its saturation is indicative of body iron stores; under normal 
conditions, only 30% of the TF iron-binding sites are saturated. TF and LF maintain the free 
iron concentration at approximately 10-18 M in body fluids, a concentration too low to 
sustain bacteria and parasite growth [Bullen, 1981]. The relative low TF saturation and high 
affinity for iron allows TF to maintain a low iron concentration in the serum, thus acting as 
 
Binding Protein 2 
the first line of defense against infections in that fluid by preventing invading 
microorganisms from acquiring the iron essential for their growth [Kaplan, 2002; 
Wandersman and Delepelaire, 2004; Halliwell and Gutteridge, 2007; Gkouvatsos et al., 2012]. 
Virtually all cells express a transferrin receptor (TFR) on their surface; the quantity of 
receptor molecules reflects the cellular iron requirement. Human TFR (HsTFR) is a 
glycoprotein of 180 kDa formed by two disulfide-bonded homodimers. The TFR/TF complex 
is endocytosed inside clathrin-coated vesicles in practically all cell types. In early 
endosomes, the content of the vesicle is acidified to approximately pH 5.5. This low pH 
weakens iron-TF binding; then, the iron is removed, reduced by a ferrireductase (Steap3), 
and transported out of the vacuole via the divalent metal ion transporter-1 (DMT1) to form 
the cellular labile iron pool (LIP); this pool consists of a low-molecular-weight pool of 
weakly chelated iron (ferrous and ferric associated to ligands) that rapidly passes through 
the cell. Both apoTF (TF without iron) and TFR return to the cell membrane to recycle the TF 
back to the bloodstream to bind iron in another cycle. At physiological pH, TFR has a much 
higher affinity for iron-loaded TF (holoTF) than for apoTF [Halliwell and Gutteridge, 2007; 
Sutak et al., 2008; Gkouvatsos et al., 2012]. There are two different TF receptors, TFR1 and 
TFR2. TFR1-mediated endocytosis is the usual pathway of iron uptake by body cells. TFR2 
participates in low-affinity binding of TF, supporting growth in a few cell types, but the true 
role of TFR2 is unknown [Halliwell and Gutteridge, 2007; Gkouvatsos et al., 2012]. 
2. Transferrin and pathogens 
The effective acquisition of iron is indispensable for the survival of all organisms. To 
survive, bacteria, fungi and parasitic protozoa in particular require iron to colonize 
multicellular organisms. In counterpart, their hosts have to satisfy their own iron 
requirements and simultaneously avoid iron capture by pathogens. It is very important to 
the host iron-control strategy to keep this element away from invading pathogens: 
intracellular and extracellular iron stores are meticulously maintained so that they are 
unavailable for invaders. As a consequence, pathogens have evolutionarily developed 
several strategies to obtain iron from the host, e.g., specialized iron uptake mechanisms 
from host iron-binding proteins, such as TF, through the use of specific TF binding proteins 
or receptors [Wilson and Britigan, 1998; Wandersman and Delepelaire, 2004; Halliwell and 
Gutteridge, 2007; Sutak et al., 2008; Weinberg 2009]. 
2.1. Prokaryotic pathogens 
Although it is out of the scope of this chapter, it is important to briefly mention as a 
reference what has been found in other pathogens such as prokaryotes. Bacteria have 
evolved specific and efficient mechanisms to obtain iron from various sources that they may 
contact in their diverse habitats and to compete for this element with other organisms 
sharing the same space. Some pathogenic bacteria can produce and secrete siderophores, 
which are low molecular-weight compounds with more affinity than the host proteins for 
Fe3+; iron-charged siderophores are recognized by bacterial-specific receptors that deliver 
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iron into the cell. Other bacteria directly bind iron from host iron compounds and proteins 
such as heme, hemoglobin, LF, TF and ferritin [Wooldridge and Williams, 1993; Wilson and 
Britigan, 1998; Wandersman and Delepelaire, 2004]. Studies in Gram negative bacteria 
describe their interactions with host iron-containing proteins through outer membrane (OM) 
receptors; the iron goes through the inner membrane (IM) and is subsequently stored. Iron 
regulates genes encoding receptor biosynthesis and the uptake of iron proteins 
[Wandersman and Delepelaire, 2004; Halliwell and Gutteridge, 2007]. 
Species of the Neisseriaceae and Pasteurellaceae families are the most studied. They acquire 
iron directly from host TF, through a receptor on the OM that contacts holo-TF and extracts 
its iron and transports it across this membrane. The receptor is formed by two proteins: TF-
binding protein A (TbpA) and TF-binding protein B (TbpB). TbpA is similar to a classical 
receptor; it is an integral membrane protein that depends on TonB for energy transduction 
between the OM and IM. TbpA transports ferric ions across the OM [Cornelissen et al., 
1992]. TbpB is a surface-exposed lipoprotein that binds TF independently [Gray-Owen and 
Schryvers, 1995]. Participation of TbpB is essential for colonizing the host and acquiring iron 
from TF and displays specificity by binding only TF from the infected animal species 
[Calmettes et al., 2011]. Once the Fe3+ is in the periplasm, it is transported to the cytosol 
through the FbpABC transporter, which is composed of FbpA, a periplasmic iron-binding 
protein, and an ABC transporter, formed by the permease FbpB and the ATP-binding 
protein FbpC [Khun et al., 1998; Nikaido, 2003; Wandersman and Delepelaire, 2004]. 
TbpB-deficient mutants of Actinobacillus pleuropneumoniae, a pathogen of the pig respiratory 
tract, are neither virulent nor able to colonize its host; thus TbpB is required for iron 
acquisition in vivo [Baltes et al., 2002; Wandersman and Delepelaire, 2004]. Surface 
lipoproteins such as TbpB have been targeted for vaccine development because they elicit a 
strong immune response, and antibodies (Abs) to this specific surface lipoprotein are 
bactericidal. Nevertheless, there is an insufficient cross-protective response induced by an 
individual receptor protein to be considered as a suitable vaccine antigen [Calmettes et al., 
2011]. The abundance of iron acquisition systems present in most pathogenic species 
undoubtedly reflects the diversity of the potential iron sources in the various niches. Some 
studies have shown that the iron acquisition systems are important determinants of 
virulence and that the inactivation of only one system decreases virulence. Bacterial OM 
receptors can show variability, enabling the pathogen to escape from the host immune 
system [Wandersman and Delepelaire, 2004]. 
2.2. Unicellular eukaryotic pathogens  
Binding proteins to host iron-containing proteins are also important determinants of 
virulence in protozoa, as has been deduced from the diversity of iron acquisition systems 
that have been identified in these protists. In this review, we discuss the current knowledge 
of transferrin binding proteins (Tbps) in some important parasites. These pathogens possess 
elaborate control systems for iron uptake from the mammalian hosts that they invade, and 
these systems ensure their success as parasites. Intracellular parasites are able to live inside 
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of a number of body cells and obtain iron from these sites; for example, in erythrocytes, 
parasites have free access to hemoglobin as an iron source, debilitating the host by causing 
anemia and other major problems. Parasites that are phagocytosed by macrophages need to 
avoid the oxidative stress response of these cells; one of these responses is the production of 
toxic radicals derived from the oxygen metabolism, and ferrous iron is responsible for their 
production by Fenton’s reaction. However, some parasites not only evade oxidative stress 
but are also able to survive and multiply inside macrophages; these parasites need to 
acquire iron for their own growth and to produce the enzyme superoxide-dismutase (SOD), 
which protects the parasites against toxic radicals. One macrophage’s strategy to prevent 
iron availability to parasites is to sequester this metal through different cleavage 
mechanisms, such as by reducing the expression of TFR1, the main cellular iron-uptake 
protein [Mulero and Brock, 1999]. Other mechanisms include increasing the synthesis of 
ferritin, the main iron-storage protein of the cell, and increasing the expression of 
ferroportin, the main protein that releases iron from the cell [Das et al., 2009]. Nevertheless, 
as we will see next, pathogenic parasites have evolved several counterstrategies to stay 
inside macrophages and acquire cellular iron. 
2.2.1. Trypanosomatids  
Trypanosomatid parasites face different challenges in their fight for iron in the diverse 
niches that they inhabit inside a host. In extra- and intracellular parasitic forms, iron plays 
roles in infection as well as in metabolism. Studies of parasite iron acquisition have led to 
extraordinary therapeutic possibilities of interfering with parasite survival inside the host.  
2.2.1.1. Trypanosoma brucei 
T. brucei is most likely the most-studied parasitic protozoan with respect to iron acquisition 
from host TF. This parasite is responsible for producing sleeping sickness or human African 
trypanosomiasis, a disease widespread throughout the African continent. It causes at least 
50,000–70,000 cases every year, which can be fatal if not treated correctly [Kinoshita, 2008]. 
The transmission vector is the tsetse fly, which inoculates T. brucei parasites in the blood of 
its mammalian host during feeding. Trypanosomiasis presents two stages: first, 
trypanosomes are observed in the hemolymphatic system, producing fever, splenomegaly, 
adenopathies, endocrine disarrays, and cardiac, neurological and psychological disorders. In 
this stage, trypanosomes multiply rapidly, infecting the spleen, liver, lymph nodes, skin, 
heart, eyes and the endocrine system. In the second stage, trypanosomes are distributed in 
the central nervous system (CNS) leading to several sensory, motor and psychic disorders 
and ending in death [Kennedy, 2005; de Sousa et al., 2010]. 
Use of host transferrin by T. brucei  
In mammals, T. brucei lives as a trypomastigote in the bloodstream and tissue fluids [Bitter et 
al., 1998; Subramanya, 2009; Taylor and Kelly, 2010; Johnson and Wessling-Resnick, 2012]. 
As an extracellular parasite, it depends on endocytosis to take up nutrients from the host 
blood [Subramanya, 2009]. This organism uses host TF as the main iron source for growth 
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and has the ability to bind TF from several origins, thus increasing its capacity to colonize a 
large range of mammals [Salmon et al., 2005]. This ability is important because by taking up 
different TFs, the parasite favors its own growth without being affected by the host immune 
system due its variability, leading to chronic infection; in this way, the ability to switch 
between different TFR genes allows T. brucei to cope with the large sequence diversity in the 
TFs of its hosts [Bitter et al., 1998; Van Luenen et al., 2005]. In contrast, T. equiperdum presents 
a restricted host range, infecting only horses [Isobe et al., 2003; Witola et al., 2005].  
T. brucei transferrin receptor (TbTFR) 
T. brucei binds TF through a transferrin receptor, TbTFR. Although TbTFR and human 
transferrin receptor (HsTFR) bind the same iron transport protein (TF), they have no 
detectable amino acid homology [Borst, 1991; Schell et al., 1991; Taylor and Kelly, 2010]. 
TbTFR is present in only bloodstream forms and not in insect forms of the T. brucei life cycle. 
In fact, T. evansi, a derivative of T. brucei, does not appear to have a life cycle stage in an 
insect vector; it presents similar TFR to T. brucei [Kabiri and Steverding, 2001]. TbTFR is 
encoded by two of the expression-site associated genes (ESAGs), ESAG6 and ESAG7, of the 
variant surface glycoprotein (VSG), the major surface antigen of the bloodstream form of T. 
brucei. ESAG6 and ESAG7 proteins evolved to bind TF [Salmon et al., 1994; Salmon et al., 
1997]. The VSG gene is at a telomeric expression site (ES) that contains at least seven 
expression-site associated genes. Each strain of T. brucei contains 20 different copies of ESAG 
with a corresponding 20 copies of TbTFR, but only a single ES is active at a time. The 
receptor expression occurs independently of the ES employed for antigenic variation [Borst, 
1991; Schell et al., 1991; Salmon et al., 1994; Salmon et al., 1997; Salmon et al., 2005; Van 
Luenen et al., 2005]. Antigenic variation prevents receptors from being recognized by the 
immune system and allows parasites to use TF from different mammalian hosts [Borst, 1991; 
Bitter et al., 1998]. The surface of the parasite bloodstream form is covered with VSG protein, 
which is required for nutrient uptake; its variability provides protection from the 
mammalian immune system [Schell et al., 1991; Taylor and Kelly, 2010]. When some 
parasites in the population switch VSG gene expression, they produce resistant phenotypes. 
VSG are powerful antigens, and the initial set of Abs is no longer useful for controlling 
trypanosomiasis. A proliferation of survivors is produced with posterior infection of the 
CNS, when parasites move across the blood-brain barrier [Kinoshita, 2008].  
TbTFR is a heterodimer consisting of ESAG7, a 42 kDa soluble protein attached to the 
membrane by the 50-60 kDa ESAG6 protein through a glycosyl-phosphatidylinositol (GPI) 
residue in the C-terminal tail [Borst, 1991; Schell et al., 1991; Ligtenberg et al., 1994; Salmon 
et al., 1994; Steverding et al., 1995; Salmon et al., 1997; Steverding, 2000; Maier and 
Steverding, 2008; Taylor and Kelly, 2010]. ESAG6 and ESAG7 can homodimerize, but only 
heterodimers bind TF; thus, each subunit provides a necessary component for the specific 
ligand-binding site [Salmon et al., 1994; Salmon et al., 1997]. The two subunits show 
differences in their C-terminal region in the four blocks of 5-16 amino acids that generate 
the ligand binding site. The sequence of the N-terminal half is highly conserved [Salmon et 
al., 1997]. Near the middle part of the gene is a hypervariable region of approximately 32 
nucleotides [Pays, 2006].  
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Affinity binding of TbTFR for TF is important when the host begins to make a significant Ab 
response against invariant regions of the receptor that could interfere with TF uptake [Borst, 
1991; Salmon et al., 1994; Steverding et al., 1995; Steverding, 2003; Steverding, 2006; Stijlemans 
et al., 2008]. In some cases, these Abs compete with TF for the receptor binding site, and only 
a high-affinity receptor could maintain the required iron level for trypanosome replication 
[Bitter et al., 1998]. Nevertheless, during the course of trypanosomiasis, Abs produced against 
the TbTFR are too low to deprive the parasite of iron [Steverding, 2006]. This factor could be 
important for the characteristic anemia observed in chronic illness, in which TF levels are 
decreased. Because iron is sequestered by macrophages and bloodstream pathogens can 
obtain iron, the “anemia of chronic infection” results, and erythropoiesis diminishes because 
there is no available iron to produce hemoglobin. Then, parasites produce a high affinity 
receptor to TF, which is present in very low quantities [Taylor and Kelly, 2010].  
There is a controversy surrounding the purpose of the TFR variability. Some authors report 
that each TFR encoded by trypanosomatids is slightly different and that these differences 
affect the binding affinity to TF from different hosts [Van Luenen et al., 2005; Pays, 2006]. 
Other researchers propose that each receptor with low or high affinity allows trypanosome 
growth independent of the in vitro or in vivo TF levels [Salmon et al., 2005]. After the synthesis 
and heterodimer formation of TbTFR, this receptor is transported to the flagellar pocket by 
the conventional route of glycoproteins. The flagellar pocket is the site for exocytosis and 
endocytosis in bloodstream trypanosomes, and it is formed by an invagination of the plasma 
membrane at the arising flagellum. This pocket protects the parasite from Abs and cell-
mediated cytotoxic mechanisms directed against important functionally conserved proteins 
such as the TFR (Fig. 1) [Balber, 1990; Borst, 1991; Schell et al., 1991; Van Luenen et al., 2005].  
 
Figure 1. Transferrin endocytosis and iron acquisition in Trypanosoma brucei. Transferrin is bound by 
the TbTFR  localized at the flagellar pocket; the complex is then internalized in clathrin-coated  
pits. The pH is acidified in the endosomes, and the iron   is released and transported to the 
cytoplasm. Apotransferrin  is degraded in lysosomes, and the TFR is recycled to the membrane by 
Rab11-positive  vesicles. 
VSG proteins leave the flagellar pocket and spread from there to cover the surface, but 
receptors such as TbTFR are prevented from spreading [Borst, 1991; Mussmann et al., 2004]. 
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Apparently, TFR is retained in the flagellar pocket by the single GPI anchor, while those that 
present two GPI anchors are targeted to the cell surface [Schwartz et al., 2005; Taylor and 
Kelly, 2010]. Then, GPI is essential for the correct formation of the VSG coat, for the 
expression of TbTFRs on the flagellar pocket, and to signal for clathrin-coated endocytosis 
[Allen et al., 2003]. The lack of TFR leads to lethality; for this reason, some authors have 
proposed the GPI biosynthetic pathway as a target for the development of anti-trypanosome 
drugs [Kinoshita, 2008]. 
Retention of the receptor in the flagellar pocket is a very regulated and saturable process. 
TbTFR expression depends on the host in which the trypanosome finds itself and on the 
quantity of iron present. Upregulation of TFR gene expression produces a mislocalization of 
the receptor onto the cytoplasmic membrane, most likely resulting in binding to more TF 
molecules. The upregulation of the receptor expression implies that the parasite can sense 
the reduction in TF availability by sensing cytosolic iron [Van Luenen et al., 2005]. 
Signal transduction and endocytosis of transferrin by clathrin-coated vesicles 
On the flagellar pocket membrane, TbTFR captures TF, and the complex is endocytosed in 
clathrin-coated pits in a saturable way [Borst, 1991; Schell et al., 1991; Salmon et al., 1994; 
Taylor and Kelly, 2010] . TF endocytosis is a temperature- and energy-dependent process 
(Fig. 1) [Ligtenberg et al., 1994; Steverding et al., 1995]. Other proteins that participate in the 
endocytosis of TF are dynamin, epsin, the adaptor AP-2 [Allen et al., 2003], and small 
GTPases such as TbRab5A, β-adaptin [Morgan et al., 2001; Pal et al., 2003], and 
phosphatidylinositol-3 kinase (PI-3K), TbVPS34 [Hall et al., 2005]. Interestingly, TbTFR does 
not discriminate between apoTF and holo-TF [Steverding et al., 1995; Steverding, 2003]. TF 
endocytosis is activated by diacylglycerol (DAG), a diffusible second messenger produced 
in GPI digestion by the GPI-phospholipase C (GPI-PLC) expressed in bloodstream T. brucei. 
GPI-PLC can cleave intracellular GPIs, producing DAG and inositolphosphoglycan. DAG 
receptors in trypanosomatids contain a divergent C1_5 domain and DAG signaling pathway 
that depends on protein tyrosine kinase (PTK) for the activation of proteins in the endocytic 
system by the phosphorylation of clathrin, actin, adaptins, and other components of this 
machinery. TF uptake depends on PTK because TF endocytosis diminishes when Tyrphostin 
A47, an inhibitor of PTK, is used in T. brucei and Leishmania mayor, another member of the 
trypanosomatid family [Subramanya and Mensa-Wilmot, 2010]. 
When the ligand-receptor complex is delivered into the endosomes, the acidic pH triggers 
the release of iron from TF and the formed apo-TF dissociates from the receptor [Steverding, 
2000]. The TFR is recycled into the flagellar pocket via TbRab11 vesicles [Steverding et al., 
1995; Jeffries et al., 2001]. TF is delivered into the lysosomes, where it is degraded by the 
cathepsin-like protein, TbcatB. A small reduction in TbcatB produces the accumulation of 
TFR within the flagellar pocket and the upregulation of TFR levels as a response to iron 
starvation [Maier and Steverding, 1996; O'Brien et al., 2008]. Later, degraded fragments are 
exocytosed by the same Rab11 vesicles (Fig. 1) [Steverding et al., 1995; Pal et al., 2003; Hall et 
al., 2005]. TbTFR has a long half-life, so the receptor is not degraded with TF but is recycled 
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back to the flagellar pocket in approximately 11 min [Kabiri and Steverding, 2000; Kabiri 
and Steverding, 2001]. 
The mechanism by which iron crosses to the cytoplasm from the endolysosomal system has 
not yet been determined; it could be through a ferric reductase. In the T. brucei genome, two 
putative ferric reductases have been found, a cytochrome b561-type (Tb927.6.3320) and an 
NADPH-dependent flavoprotein (Tb11.02.1990). These enzymes could act in cooperation 
with some divalent putative cation transporters, but none of them have been related with 
iron transport [Taylor and Kelly, 2010]. 
Iron storage 
Depending on the growth conditions, TbTFR can be found at very low concentrations of 
approximately 1.0 – 2.3 x 103 molecules per cell [Borst, 1991; Steverding et al., 1995] or 1.88 – 
2.71 x 104 molecules per cell [Salmon et al., 1994]; thus, the parasite is very efficient at taking 
iron from TF. TF is taken up at rates 100–1000 times higher than those for phase fluid 
endocytosis [Borst, 1991]. The iron necessity is approximately 85,000 Fe3+ 
ions/parasite/generation [Steverding et al., 1995] to 1.4 x 106 atoms/trypanosome [Schell et al., 
1991], but its requirements are approximately 40,000 Fe3+ per generation [Steverding, 2003]. 
For this reason, it is possible that T. brucei accumulates iron in some way [Steverding et al., 
1995]. When iron provisions are depleted due to TF starvation, a rapid increase in TbTFR 
takes place, and the capacity to capture TF increases [Mussmann et al., 2004]. During chronic 
trypanosomiasis in cattle, anemia occurs, in which the host TF level is decreased and the 
bloodstream pathogens develop the ability to grow at very low iron concentrations 
[Steverding et al., 1995]. It is in this stage of iron deprivation and chronic infection when a 
TFR other than TbTFR, with higher affinity for its ligand, is produced; this occurs because 
TbTFR is not able to discriminate between holo- and apo-TF [Taylor and Kelly, 2010]. 
Iron chelation and therapeutic improvement 
In the absence of iron, the parasite DNA synthesis rate decreases, oxidative stress levels 
increase, electron transfer stops, and other functions are affected, all of them leading to 
death. Iron chelation affects T. brucei growth; thus, it could be a therapeutic method for 
combating the infection. The iron chelator deferoxamine (DFO) prevents iron incorporation 
in newly synthesized enzymes, decreasing the growth rate and oxygen consumption [Taylor 
and Kelly, 2010]. Acute iron starvation leads to a rapid increase in TbTFR, allowing an 
increased capacity to uptake TF [Mussmann et al., 2004].  
TbTFR is immunologically important, and it has been studied for its antigenic potential in 
the production of vaccines. Using the complete collection of TFRs as a vaccine, the 
proliferation of trypanosomes was blocked; however, some authors are not convinced and 
suggest that antigenic variation makes the production of a vaccine against sleeping sickness 
improbable [Kinoshita, 2008]. ESAGs could also be targets for immune attack. Flagellar 
pocket proteins were used for immunization of mice and were able to confer protection 
against superinfection with trypanosomes [Olenick et al., 1988]. A functional TbTFR was 
expressed in insect cells and could be helpful in crystallographic studies to determine the 
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structure and characterize the interface between TF and its receptor, which could lead to a 
new approach to combat infection [Maier and Steverding, 2008]. TF uptake is very 
important in trypanosomes for obtaining iron, so endocytic uptake systems were developed 
earlier in evolution compared with TF endocytosis in mammalian cells. Nevertheless, this 
process has numerous similarities between the two groups. 
2.2.1.2. Trypanosoma cruzi 
This parasite causes human Chagas disease, a chronic and debilitating condition affecting 40 
million people in Africa, South America, Europe, and Asia, according to data of the World 
Health Organization (WHO). T. cruzi is transmitted either by an insect vector that has access 
to the host via breaches in the skin or through mucosal membranes, mainly the conjunctiva 
or the gastric mucosa. It is an obligate intracellular parasite that disseminates from the initial 
infection site to the heart and smooth muscle, with several rounds of invasion, growth and 
egression from infected cells during acute infection. Very little is known regarding the early 
interaction between the parasite and its host that facilitates the establishment of infection 
[Mott et al., 2011]. 
T. cruzi transferrin receptor (TcTFR) and endocytosis 
It has been suggested that the internalization of TF is mediated by a receptor in T. cruzi. 
However, until now, there is no biochemical evidence of the presence of a TFR. 
Epimastigote forms of T. cruzi could use a TFR to obtain iron and transport TF through 
uncoated vesicles formed in the most posterior portion of the cytostome/cytopharynx 
system, a plasma membrane invagination that penetrates deeply into the cytoplasm towards 
the nucleus. All the endocytic vesicles formed in the cytostome are uncoated and are 
associated with lipid raft markers in detergent membrane-resistant (DMR) domains [Correa 
et al., 2007]. Endocytic vesicles originate either from the cytostome or from the flagellar 
pocket, and they fuse with early endosomes and then with reservosomes (prelysosomal 
compartments); endocytosed TF is taken into the reservosomes, which are structures that 
present numerous proteases [Correa et al., 2008; Cunha-e-Silva et al., 2010; Rocha et al., 2010]. 
Other proteins that participate in endocytosis have been identified, such as TcRab7, an 
indicator of high traffic between the Golgi apparatus and reservosomes, and TcRab11, which 
is involved in the recycling process [Cunha-e-Silva et al., 2010; Rocha et al., 2010]. 
Amastigote forms replicate in the host cell cytoplasm, where TF is almost absent, so the 
relevance of these forms during infection is not clear. The importance of the receptor is 
observed in trypomastigotes in the bloodstream and epimastigotes in bloodmeal, where TF 
was observed in the reservosome [Soares and de Souza, 1991; Soares et al., 1992].  
Iron chelation 
There is not enough information about how cytoplasmic iron is taken up by T. cruzi 
parasites. They replicate in macrophage cytoplasm; therefore, the macrophage iron-
withholding response would benefit the parasite, allowing access to iron [Taylor and Kelly, 
2010]. An increase of parasitemia and mortality associated with high levels of iron were 
observed, as was a reduction in parasitemia with the use of chelants such as DFO or 
 
Binding Protein 10 
benznidazole [Lalonde and Holbein, 1984; Taylor and Kelly, 2010; Johnson and Wessling-
Resnick, 2012]. The obtained iron is stored in specialized electron-dense organelles; these 
organelles are different from lysosomes and reservosomes [Scott et al., 1997]. The infection in 
mouse models involves the production of anemia. This anemia is due to interference with 
the stimulation of the IFN-induced GTPase LRG-47, which produces severe effects in the 
hematopoietic system [Taylor and Kelly, 2010]. When the parasite is extracellular, it must 
obtain nutrients from host proteins. The possibility of infecting several organisms makes it 
possible that this parasite could use different iron sources, including TF. Because TF 
accumulation reported an organelle in which TF could be accumulated could exist. Very 
little is known about the T. cruzi iron uptake mechanisms either in its different extracellular 
or intracellular forms of its life cycle. 
2.2.2. Entamoeba histolytica 
E. histolytica is the causal protozoan agent of amoebiasis in humans, a disease characterized 
by dysentery and intestinal ulcers. The parasite is able to invade and destroy tissues, 
affecting not only the large intestine but also other extra-intestinal organs such as the liver; 
these infections can be fatal. Amoebiasis shows high level of morbidity and mortality 
worldwide, particularly in developing countries. Worldwide, 500 million people are infected 
with E. histolytica, causing disease in 50 million and 100,000 deaths each year [Ali et al., 2008; 
Anaya-Velázquez and Padilla-Vaca, 2011]. 
Iron and E. histolytica 
Iron is essential for E. histolytica trophozoites living inside the human host because these 
parasites require a high quantity of iron (approximately 100 μM) for growing in vitro and 
are able to use iron from several iron-binding proteins [López-Soto et al., 2009b]. High 
amoebic damage was caused in the liver of hamsters that were fed with ferrous gluconate. 
In addition, there is a significant relationship between amoebic growth and the mechanisms 
of iron acquisition modulated by determinants of virulence [Diamond et al., 1978; Smith and 
Meerovitch, 1982]. Within the host, amoebae face the hostility of nonspecific defense 
systems such as oxidative stress and the lack of nutrients. Several protective mechanisms 
have been developed by E. histolytica, such as the induction of the superoxide dismutase 
(SOD) gene under iron-limited conditions; this enzyme defends amoeba from the toxicity 
and damage caused by oxygen metabolites. Thus, SOD is useful during tissue invasion, 
when amoebae are exposed to great amounts of superoxide radicals [Bruchhaus and 
Tannich, 1994a]. 
If iron is reduced in the culture medium to < 20 μM, amoebae do not survive. Several 
studies have shown responses of the parasite to the absence or excess of iron and to the 
presence of iron-containing proteins [Serrano-Luna et al., 1998; Reyes-López et al., 2001; 
León-Sicairos et al., 2005; López-Soto et al., 2009a]. The concerted use of strategies to bind 
and use iron from different sources provides the parasite with the ability to use various host 
proteins for its benefit. In the absence of iron, E. histolytica expresses several genes that 
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encode for cysteine proteases CP1, CP2 and CP3; these proteases are virulence factors, as 
they degrade the mucus barrier in the intestinal epithelium. However, there is no 
information concerning the mechanisms for iron regulation in this parasite. Genes involved 
in translation were identified to be expressed in the absence of iron [Park et al., 2001], as 
occurs with the ferric uptake regulator (Fur) in bacteria and in iron responsive element (IRE) 
and IRE-binding proteins of mammalian cells [Wang et al., 2007]. 
Use of host iron-containing proteins 
E. histolytica has developed specific mechanisms to obtain iron from host iron-containing 
proteins. This assertion is based on the parasite growth in vitro in media depleted of iron 
and to which different iron proteins have been added. Trophozoites have been tested in 
cultures with hemoglobin, LF, TF, ferritin, and as the sole iron sources, and all of them have 
been utilized by the parasite for growth [Serrano-Luna et al., 1998; Reyes-López et al., 2001; 
León-Sicairos et al., 2005; López-Soto et al., 2009b]. In this way, amoebae could ensure the 
presence of iron for the colonization of the different organs and tissues involved in amoebic 
infection. 
E. histolytica transferrin binding proteins, EhTFbps  
Iron-loaded TF (holoTF) but not apoTF binds to the E. histolytica trophozoite surface. 
Interestingly, this parasite has two methods of obtaining iron from TF: one is mediated by 
receptor-independent internalization [Welter et al., 2006] and the other is through three 
specific TF-binding proteins (EhTFbps) of 70, 96 and 140 kDa of molecular mass, identified 
by overlay assays with holoTF. The 140 kDa protein is recognized by an anti-HsTFR mAb 
B3/25 (Boehringerheim cat. No. 1118-048), and the 96 kDa protein is recognized by the anti-
HsTFR mAb H68.4 (Zymed cat. No. 13-6800). Apparently, the EhTFR forms a complex with 
TF to be endocytosed (Fig. 2). Using pharmacological and immunofluorescence microscopy 
studies, the participation of clathrin protein in the endocytic process was demonstrated. 
Once inside the vacuoles, TF is transported into the endolysosomal system [Reyes-López et 
al., 2001; Reyes-López et al., 2011]. However, when the endocytic process was followed using 
high TF concentrations, the TF was internalized independently of the binding protein 
[Reyes-López et al., 2011]. This result is in agreement with the observation that TF 
internalization is unsaturable [Welter et al., 2006]. The presence of clathrin has been 
demonstrated in some protozoa [Morgan et al., 2001] and in E. histolytica [León-Sicairos et al., 
2005; López-Soto et al., 2009a; Reyes-López et al., 2011]; clathrin may be important in 
parasites for the acquisition of nutrients. The gene encoding the clathrin protein has been 
identified in the E. histolytica genome [Loftus et al., 2005]. Once inside the lysosomes, TF 
could be degraded by specific cysteine proteases (Fig. 2) (our unpublished data), as was 
observed in T. brucei. 
In addition to the phagocytosis of erythrocytes to use hemoglobin, the direct binding of host 
TF to specific proteins on the amoeba surface may be another strategy used to capture iron 
in the blood and liver, which is important in the human host invasion process of this 
parasite. The 96 kDa protein was identified as the enzyme acetaldehyde/alcohol 
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dehydrogenase-2 (EhADH2) by mass spectrometry after its isolation by 
immunoprecipitation with the mAb H68.4 [Reyes-López et al., 2011]; to our knowledge, this 
report is the first in which an enzyme was shown to bind TF in parasitic protozoa. 
Internalization of TF through a receptor is a fast, saturable, and temperature-, time-, and 
concentration-dependent process. It is possible that the EhADH2 protein, which requires 
iron for its activity, participates in the regulation of iron-Tf uptake and utilization. EhADH2 
enzyme is essential for amoeba survival and is able to discriminate between iron-loaded TF 
and apoTF, possibly because iron is the enzyme cofactor of the protein [Espinosa et al., 2009].  
 
Figure 2. Transferrin endocytosis in  Entamoeba histolytica. HoloTF is detected by the EhTbp  and 
the TFR  and internalized in clathrin-coated  pits. 
It has been reported that bacteria such as Staphylococcus aureus and Staphylococcus epidermidis 
use the enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to bind TF [Modun 
and Williams, 1999], and the parasite Trypanosoma brucei uses an organelle in which TF 
could be accumulated could exist.GAPDH for binding LF rather than TF [Tanaka et al., 
2004]. Apparently, glycolytic enzymes have several functions; an example is enolase, which 
also regulates the activity of cytosine 5-methyltransferase 2 (Dnmt2), an enzyme that 
catalyses DNA and tRNA methylation in amoeba [Tovy et al., 2010]. The EhADH2 amino 
acid sequence and that predicted for the HsTFR are not similar, so the recognition of both 
proteins by the mAb could be explained by a structural connection. EhADH2 is an essential 
enzyme used for obtaining energy by glucose fermentation [Bruchhaus and Tannich, 1994b; 
Yang et al., 1994; Flores et al., 1996; Espinosa et al., 2001; Avila et al., 2002; Chen et al., 2004; 
Espinosa et al., 2004; Espinosa et al., 2009]. Due to the properties of EhADH2, such as its 
ability to bind to host extracellular matrix proteins, its presence on the cell membrane, and 
its requirement for iron, the blocking of this enzyme with iron chelators as a therapeutic 
strategy against E. histolytica is an interesting future perspective [Espinosa et al., 2009].  
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EhTFbp is able to bind TF with either high or with low affinity (1.81 and 1.1-5.7 x 10-9 M). 
This observation could be due to the presence of two binding proteins or only one protein 
with two different affinities [Reyes-López et al., 2011]. Comparing the affinity for TF in 
bacteria (0.7 a 4 x 10-7 M) [Pintor et al., 1993] and Trypanosoma cruzi (2.8 X 10-6 M) [Testa, 
2002], the amoebic receptor presents the higher affinity. The fact that E. histolytica 
trophozoites possess a variety of mechanisms to obtain iron from TF is advantageous to the 
parasite. However, in amoebiasis, the host usually has lower iron levels and TF saturation 
than that showed in uninfected people; this defense is a normal response to limit iron from 
pathogens during infection, a phenomenon known as hypoferremia of infection [Van Snick 
et al., 1974; Otto et al., 1992; Jurado, 1997; Griffiths et al., 1999; Weinberg, 1999; Weinberg 
2009]. Further studies are necessary to comprehend the role of all the proteins that 
participate in the iron acquisition system of TF and in the iron metabolism of this important 
parasite.  
2.2.3. Tritrichomonas foetus 
T. foetus is a venereal protozoan pathogen of cattle that infects the female genital tract, 
resulting in abortion, endometritis, and infertility [Manning, 2010; Pereira-Neves et al., 2011]. 
This parasite has a worldwide distribution and causes significant economic losses to cattle 
producers. Strains of T. foetus have also been recognized that cause diarrhea in cats [Gookin 
et al., 1999] and mild rhinitis in swine [Lun et al., 2005]. As an obligate parasite, T. foetus 
depends on endogenous bacteria and host secretions for nutrients such as iron. This 
organism has high iron requirements for in vitro cultivation (50–100 μM) [Tachezy et al., 
1996], surpassing those of eukaryotic cells, although comparable to other anaerobic 
amitochondriate protists. T. foetus inhabits the vagina, cervix, and the lumen of the bovine 
uterus, with the last one being characterized as rich in TF [Roberts and Parker, 1974]. 
Therefore, TF could be an important source of iron for T. foetus. 
The involvement of iron and holo-TF in T. foetus virulence has been examined in 
experimental infection of mice with the moderately virulent KV-1 strain (~5% mortality 
rate). Administration of ferric ammonium citrate to infected mice increased the mortality 
rate to the level associated with the highly virulent LUB-1MIP strain (~80% mortality rate) 
[Kulda et al., 1999]. When examined in vitro, the KV-1 strain showed significantly lower iron 
acquisition from holo-TF and low molecular mass complexes than the highly virulent strain. 
These data indicate a correlation between strain virulence and iron acquisition from holo-TF 
[Kulda et al., 1999]. Growth of parasites using holoTF as a sole iron source has been reported 
in vitro [Tachezy et al., 1996]. Accordingly, iron from 59Fe-TF was efficiently accumulated 
into T. foetus, specifically in the labile iron pool (LIP). Interestingly, the concentration of 
protein-bound iron that restored 50% cell growth (5 μM for Fe-TF) was approximately 5-fold 
lower than that of low molecular weight iron complexes [Tachezy et al., 1996; Suchan et al., 
2003], indicating that T. foetus uses TF iron more efficiently. This finding agrees with results 
in studies of other pathogens that require higher iron concentrations from these complexes 
than those from host proteins (holoLF and HG) [Wilson et al., 1994; Jarosik et al., 1998]. 
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Retrieval of iron from TF may depend on the extracellular release of iron from this ligand 
caused by the acidification of the microenvironment by T. foetus [Tachezy et al., 1996]. This 
hypothesis is based on the observation that the pH of the conditional media decreased from 
pH 7.4 to 5.6 after incubation with T. foetus. As predicted at this pH, there was a marked 
release of iron from holoTF (up to 47%) measured in the cell-free medium (Fig. 3) [Tachezy 
et al., 1996]. Iron uptake from TF was almost exponential, which possibly reflected the 
accelerated release of iron from the protein by the acidification of the cellular 
microenvironment [Tachezy et al., 1996]. Nevertheless, further studies are needed to 
demonstrate the actual role of microenvironmental acidification in iron uptake, for example, 
by measuring the iron uptake by T. foetus using a stronger buffered medium to prevent 
acidification. 
Iron uptake from transferrin in T. foetus 
Iron uptake from TF is a process dependent on the energy produced by glycolysis, as 
sodium fluoride affected the uptake [Tachezy et al., 1998]. The mechanism also involves 
extracellular iron reduction from holo-TF. This idea is supported by the inhibitory effect 
of BPSA (a membrane impermeable, ferrous-iron specific chelator) on iron uptake from 
holo-TF, as iron is originally in the ferric state in this molecule. Additionally, the presence 
of ascorbic acid, a strong reducing agent, stimulated iron accumulation by T. foetus from 
holo-TF [Tachezy et al., 1998]. Which mechanism is actually used by T. foetus to reduce 
holo-TF iron is unknown. Iron released from holo-TF could be acquired by a mechanism 
related or identical to that used for acquisition from the low molecular weight iron 
chelator nitrilotriacetic acid (Fe-NTA) because these processes displayed similar kinetics 
and susceptibility to various agents [Tachezy et al., 1998]. Iron uptake from Fe-NTA by 
this microorganism also depends on iron reduction and is better characterized. 
Extracellular iron reduction from Fe-NTA seems to be non-enzymatic, as the reduction 
activity is thermo-labile and unaffected by proteases, and the majority is filterable 
through a membrane with a cut-off of 3 kDa. Additionally, iron acquisition is not 
enhanced by the presence of NADH, a nucleotide reported to provide electrons to 
ferrireductases [Low et al., 1986; Berczi and Faulk, 1992; Riedel et al., 1995]. In fact, 
trichomonads are able to produce reducing volatile agents such as H2S [Thong and 
Coombs, 1987] or methanethiol [Thong et al., 1987], which have been suggested to 
participate in oxygen detoxification [Thong et al., 1986]. It could be that trichomonads are 
able to take advantage of their reducing environment to take up iron from holo-TF (Fig. 
3). This hypothesis needs to be tested and does not completely rule out the possibility that 
a ferrireductase may also participate. 
The extracellular release of iron from holo-TF could be independent of proteolysis because 
less than 40% of the parent molecule was digested even after 24 h of contact with 
extracellular T. foetus proteases [Talbot et al., 1991]. Iron acquisition from TF seems to be 
independent of endocytosis because lysosomotropic bases such as ammonium chloride 
and chloroquine acting as inhibitors of endosome acidification did not decrease iron 
accumulation from TF [Tachezy et al., 1998]. However, work from Affonso shows that 
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endocytosis of TF by T. foetus actually takes place [Affonso et al., 1994]. It was shown that 
TF binds to the parasite surface, and because unlabeled TF does not compete with labeled 
TF, this binding does not seem to be through specific surface receptors. In agreement with 
this result, holo-TF binding does not display saturable kinetics [Tachezy et al., 1996]. The 
initial binding of gold-labeled human TF may be due to low-affinity interactions, as 
occurs with T. vaginalis [Peterson and Alderete, 1984]. Gold-labeled TF is internalized by 
the parasite through endocytic vesicles and concentrated into vacuoles of variable 
dimension, peripheral tubular and tubulovesicular structures all without a typical clathrin 
coat. The absence of a specific receptor suggests a principal role for fluid phase 
endocytosis [Tachezy et al., 1996].  
 
Figure 3. Transferrin acquisition in Plasmodium falciparum. The parasite produces its receptor by an 
unknown mechanism. The receptor is transported to the erythrocyte membrane, where it is able to bind 
TF . Then the iron from TF is transported back to the parasite by an unknown mechanism. 
Further studies are necessary to fully understand the mechanism of iron acquisition from 
holoTF by T. foetus, specifically to characterize the mechanism of iron reduction and of iron 
transport through the membrane and to clarify the role of holo-TF endocytosis in iron 
acquisition. Moreover, due to its unusually high nutritional requirement for iron, the 
inhibition of iron uptake from holo-TF might be an attractive therapeutic strategy against T. 
foetus.  
 
Binding Protein 16 
2.2.4. Plasmodium spp. 
Malaria is a mosquito-borne infectious disease of humans and other animals caused by 
parasite protozoa of the genus Plasmodium. The disease results from the multiplication of 
parasites inside red blood cells (erythrocytes), causing fever, headache, splenomegaly, 
cerebral ischemia, hepatomegaly, hypoglycemia, and hemoglobinuria with renal failure, 
progressing in severe cases to coma and death [Trampuz et al., 2003]. It is widespread 
mainly in the tropical and subtropical regions of Sub-Saharan Africa, Asia, and America. 
Five species of malaria can be transmitted to humans. Severe disease is largely caused by P. 
falciparum, while the diseases caused by P. vivax, P. ovale [Sutherland et al., 2010] and P. 
malariae are generally milder and rarely fatal. P. knowlesi is a zoonosis that causes malaria in 
macaques but sometimes can infect humans [Fong et al., 1971; Singh et al., 2004]. Malaria has 
been a widely prevalent disease throughout human history. The World Health Organization 
has estimated that malaria annually causes 250 million cases [WHO, 2008]. In 2010, it was 
estimated that 655,000 people died from the disease [WHO, 2010]. However, a 2012 meta-
study published in The Lancet reported 1,238,000 people dying from malaria in 2010 [Murray 
et al., 2012]. The majority of cases occur in children under 5 years old [Greenwood et al., 
2005]; pregnant women are also especially vulnerable. P. falciparum is responsible for the 
vast majority of deaths associated with the disease [Snow et al., 2005].  
The life cycle of malaria parasites in the human body begins when a mosquito infects a person by 
taking a blood meal. Malaria develops via two phases: an extra-erythrocytic and an intra-
erythrocytic phase. The extra-erythrocytic phase involves infection of the hepatic system, 
whereas the intra-erythrocytic phase involves infection of erythrocytes. When an infected 
mosquito pierces a person's skin, sporozoites in the mosquito's saliva enter the bloodstream and 
migrate to the liver, infecting hepatocytes, multiplying asexually and asymptomatically for a 
period of 8–30 days. After this dormant period in the liver, parasites differentiate to yield 
thousands of merozoites, which, following rupture of their host cells, escape into the blood and 
infect red blood cells [Bledsoe, 2005]. The parasite escapes from the liver undetected by wrapping 
itself with the host cellular membrane. Within the red blood cells, the parasites multiply further, 
again asexually, periodically breaking out of these cells to invade fresh red blood cells. Several 
such amplification cycles occur [Sturm et al., 2006]. The parasites are relatively protected from 
attack by the body's immune system because they reside within the liver and blood cells and are 
relatively invisible to immune surveillance for most of their life cycle in humans. However, 
circulating infected blood cells are destroyed in the spleen [Chen et al., 2000]. 
P. falciparum parasites need iron to support their growth 
Treatment with iron supplementation in Plasmodium-infected patients increases malaria 
morbidity [Oppenheimer, 1989]. Interestingly, despite the fact that the intra-erythrocytic 
parasite is surrounded by hemoglobin, it is unable to utilize this ferrous molecule, and 
therefore, heme accumulates in hemozoins (crystalline particles) within the parasites [Roth et 
al., 1986; Goldberg et al., 1990]. The delivery of extracellular iron from serum TF to infected 
erythrocytes has been postulated [Pollack and Fleming, 1984; Haldar et al., 1986; Rodriguez 
and Jungery, 1986]. The uptake of 125I- or 55Fe-labeled human TF has been detected in 
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parasitized cells during several days of culture [Pollack and Fleming, 1984]. Furthermore, two 
independent studies have reported the identification of proteins on the surface of P. 
falciparum-infected erythrocytes that have an affinity for ferric TF [Haldar et al., 1986; 
Rodriguez and Jungery, 1986]. Rodriguez and Jungery [Rodriguez and Jungery, 1986] 
described the presence of a 93 kDa protein that bound to a TF affinity-column. These authors 
claim that this protein could be a parasite-derived TFR, synthesized by P. falciparum (PfTFR), 
because the vast majority of mature erythrocytes lack the expression of TFR (CD71) [Marsee 
et al., 2010]. Almost at the same time, Haldar et al. [1986] identified another probable PfTFR of 
102 kDa synthesized by the intracellular parasite and inserted in the erythrocyte membrane 
of mature infected cells. This protein recognizes only holoTF. Biochemical analysis indicated 
that this protein is acylated via 1,2-diacyl-sn-glycerol, which may be important for its 
association with the membrane. Fry [1989] described a diferric reductase activity in P. 
falciparum-infected erythrocytes. This activity was absent in uninfected mature erythrocytes, 
suggesting its synthesis and incorporation by P. falciparum. The author suggests that the 
presence of the diferric TF reductase together with the parasite–derived TFR in the 
erythrocyte membrane could form a TFR –mediated uptake mechanism.  
 
Figure 4. Tritrichomonas foetus uptake of iron from Transferrin by a reducing mechanism. HoloTF  
binds Tritrichomonas surface most likely through low-affinity interactions, and then iron is released due 
to the microenvironment acidification. Ferric iron  is reduced to the ferrous  form by an 
unknown mechanism, most likely non-enzymatic, and is then internalized by the parasite to become 
part of the labile iron pool (LIP). 
In contrast, a controversial study performed by Pollack and Vera Schnelle in [1988] was 
unable to detect a TFR in P. falciparum-infected erythrocytes. This study concluded that the 
binding of TF to the erythrocyte surface was not specific because it was neither saturable nor 
limited to TF, as LF and albumin were also bound to the parasitized cells. These authors 
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suggested that TF was non-specifically bound and in this way endocytosed and degraded 
inside the parasite. Furthermore, in [1992], Sánchez-López and Haldar described a TFR-
independent iron uptake activity in P. falciparum, and this activity was also apparent in 
uninfected erythrocytes. These authors demonstrated that normal levels of TF in human 
serum were not required for intra-erythrocytic P. falciparum growth. However, although the 
iron uptake activity was not parasite specific in parasitized erythrocytes, apparently 
radiolabeled iron (55Fe) was found in association with parasites mechanically released from 
the infected erythrocyte, indicating that it was delivered to the intracellular organism.  
In view of the controversial state of the research regarding to Plasmodium TF iron uptake, we 
think that more careful studies have to be performed to determine whether there is a 
complete PfTFR in parasitized erythrocytes, in which state the iron travels through the 
erythrocyte cytoplasm until reaching the parasitic surface, and lastly, how iron is internalized 
by the parasite (Fig. 4). Another interesting question is that if P. falciparum can obtain iron 
from different sources, which of these sources are important in parasitic iron uptake  
2.2.5. Leishmania spp. 
Leishmania species are dimorphic-protozoa that cause leishmaniases, a range of diseases 
displaying a large spectrum of clinical symptoms in mammals. Approximately 2 million 
new cases occur every year, with an estimate of 150 million people infected around the 
world [Kaye and Scott, 2011]. Five main species of Leishmania can infect human beings: L. 
tropica, L. major, L. donovani, L. braziliensis and L. mexicana. There are mainly three clinical 
forms of infection: the self-healing cutaneous leishmaniasis (CL), the mucocutaneous 
leishmaniasis (MCL), and the often fatal visceral leishmaniasis (VL) that affects people of the 
South American continent. The severity of symptoms depends on the parasite species and 
strain; exposure dose; and genetic, health and immune status of the host [Anstead et al., 
2001; Marquis and Gros, 2007; Kaye and Scott, 2011].  
Leishmanias can live in two stages: flagellated promastigotes and non-flagellated 
amastigotes. When promastigotes are inoculated in the host human dermis by the vector 
insect (sandfly), they are phagocytosed by macrophages, and then transform into 
amastigotes within a membrane-rounded organelle named the parasitophorous vacuole 
(PV) that belongs to the endocytic route, and progressively acquires characteristics of a late 
endosome/lysosome [Courret et al., 2001; Courret et al., 2002]. Inside the PV, the parasites 
replicate leading to cell lysis, and free parasites infect the surrounding cells. Leishmanias 
surviving intracellularly produce multiple effects in phagocytes: inhibition of the respiratory 
burst, prevention of apoptosis, chemotaxis inhibition in both macrophages and neutrophils, 
and suppression of the Th1 type protective response [Olivier et al., 2005].  
Some species of Leishmania possess specific transferrin binding proteins  
More than 20 years ago, a putative TF binding protein in L. infantum promastigotes was reported 
[Voyiatzaki and Soteriadou, 1990]. The binding of human iron-free 125I-TF to Leishmania-purified 
membrane preparation was found of high affinity (Kd 2.2 x 10-8 M); in addition, this binding was 
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saturable and specific for TF. The affinity of the LiTbp for TF is comparable with that reported in 
mammalian cells. Interestingly, the anti-human TFR mAb B3/25, which recognizes a Tbp of 140 
kDa in E. histolytica, did not recognize the LiTbp, suggesting that the HsTFR and LiTbp do not 
share epitopes. Binding of human apo-TF was also tested on living avirulent L. infantum 
promastigotes, and on L. mexicana amastigotes obtained from infected mice with promastigotes. 
In both cases the binding was specific and saturable, suggesting that the LiTbp is functionally 
similar to the human TFR. Although the experiments were performed with iron-free TF, these 
data suggest that both stages of Leishmania are able to bind human TF, an important iron protein 
for the parasite iron requirement; indeed, TF-mediated uptake of iron was observed in these 
parasites. Later, the same authors isolated and identified the LiTbp as an integral membrane 
monomeric glycoprotein of 70 kDa [Voyiatzaki and Soteriadou, 1992]. The purification of this 
receptor was carried out through the use of affinity chromatography with human TF from 
membrane preparations of L. infantum and L. major promastigotes.  
 
Figure 5. Iron uptake from Transferrin by Leishmania chagasi promastigotes. A non-specific receptor, 
LcTbp , binds TF , allowing a parasite-associated or secreted reductase to reduce the ferric iron 
 from holoTF, and in this way, the TF affinity for iron diminishes, allowing ferrous iron  to be 
internalized by the parasite. 
L. chagasi also showed a 70 kDa protein that binds TF (LcTbp); however, this protein is not 
specific for TF because LF and albumin were also bound. Apparently, a parasite-associated 
or secreted reductase is needed to reduce the ferric iron from holoTF, and in this way, the 
affinity of TF for iron diminishes allowing iron be internalized by the parasite (Fig. 5) 
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[Wilson et al., 2002]. L. chagasi promastigotes require a lower iron concentration than other 
parasites (8 μM hemin). Lactoferrin, as an extracellular protein, interacts with 
promastigotes, and it can be used by them as an iron source in vitro [Wilson et al., 1994]. 
Promastigotes were able to take up 59Fe-LF more rapidly than that from hemin or holoTF, 
suggesting that iron uptake from holoTF and holoLF occurs via a non-specific receptor 
because apoLF, apoTF and holoTF competed with holoLF for the uptake. In other 
experiments [Britigan et al., 1998], it was demonstrated that the binding to TF is markedly 
greater if this protein is iron-charged; also, if L. chagasi does not excrete proteases that cleave 
TF, then the proteolytic cleavage is not a mechanism to obtain iron in this parasite.  
Leishmania can live inside macrophages  
The access of iron inside the macrophage's phagosome plays a central role in Leishmania 
infection. Nramp1 protein is located in macrophage lysosomes and in tertiary granules of 
neutrophils, and it is rapidly recruited towards the membrane of leishmania-containing 
phagosomes. In that membrane, the iron transporter protein Nramp1 chelates Fe2+ in the 
intraphagosomal environment and in this way, Nramp1 avoids the parasite multiplication 
and activation of macrophages. However, L. amazonensis upregulates the expression of its 
own ferrous iron transporter LIT1 after being endocytosed by the macrophage. Mutations in 
Nramp1 (Slc11a1) gene are responsible of mouse propensity to be infected with Leishmania 
because macrophages permit its replication [Forbes and Gros, 2001; Marquis and Gros, 2007; 
Huynh and Andrews, 2008; Jacques et al., 2010].  
 
Figure 6. Iron uptake by intracellular Leishmania donovani amastigotes. From its parasitophorous 
vacuole (PV), Leishmania expresses its ferrous iron transporter (LIT1) to scavenge iron  and deplete 
the macrophage labile-iron pool (LIP); this activates the host cytosolic iron-responsive element sensor 
proteins IRP1 and IRP2. These proteins increase the stability of the TFR mRNA  , increasing 
macrophage iron uptake from TF and the intracellular iron parasite needs for survival. 
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Interestingly, studies with L. donovani suggest that there is an intraphagosomal competition 
for free ferrous-iron between the iron transporters from host and those from the parasite. This 
competition may, by depleting the macrophage labile-iron pool (LIP) (Fig. 6), activate the host 
cytosolic iron-responsive element sensor proteins IRP1 and IRP2. These proteins increase the 
stability of the mRNA of the TFR by binding to iron-responsive elements (IREs) present in the 
3´UTR of the TFR1 gene, which in turn leads to increased production of the TFR1 and, thus, 
to TF-mediated iron uptake [Das et al., 2009]. In this study, the authors clearly demonstrate 
that instead of macrophages sequester iron, virulent parasites directly scavenge iron from the 
host LIP (Fig. 6), which activates the interaction IRE-IRP leading to an up-regulation of the 
macrophage´ TFR1, increasing the intracellular iron needed for parasite survival. 
2.2.6. Toxoplasma gondii 
Toxoplasma gondii is an intracellular obligate protozoan that belongs to the phylum 
Apicomplexa and is unique in invading a large diversity of mammals and birds [Ossorio et al., 
1994; Ajioka et al., 1998; Joiner and Roos, 2002]. It is thought that approximately 25% of the 
world human population is infected by Toxoplasma [Tenter et al., 2000]. Toxoplasmosis can 
produce severe damage in humans with often fatal results, mainly in immunosuppressed 
patients suffering from AIDS or cancer and in people undergoing immunosuppressive 
treatments. The most frequent damages include chorioretinitis with consecutive loss of 
vision and damage to the CNS, lungs, and heart, and when infection occurs during 
pregnancy, parasites reach the placenta and infect the fetus, causing abortion [Luft and 
Remington, 1992; Barragan and Sibley, 2002]. However, in immune competent people, 
infection occurs in a transitory and asymptomatic fashion. The success of T. gondii as an 
intracellular pathogen is based on its high capacity for invasion and dissemination in 
practically all tissues due to its migration through biological barriers such as intestinal, 
hematic-encephalic, hematic-ocular, and placental; parasites can be detected in amniotic, 
cerebrospinal, bronchoalveolar, ocular, pleural and ascitic fluids, as well as in urine and 
peripheral blood [Derouin and Garin, 1991; Barragan and Hitziger, 2008; Unno et al., 2008]. 
Due to the high incidence of toxoplasmosis in AIDS patients, in the last few years, much 
attention has been placed on the pathology caused by this parasite.  
The T. gondii life cycle involves two types of hosts: definitive hosts, which include members 
of the Felidae family such as the domestic cat in which the sexual reproduction cycle takes 
place, and intermediate hosts, which include warm-blood animals such as cattle, sheep, pigs, 
and humans in which asexual reproduction occurs [Dubey, 1998; Tenter et al., 2000]. Parasite 
replication takes place in the gut, resulting in the production of oocysts, which are shed in the 
feces. After sporulation, the resultant sporozoites are infective when ingested by humans and 
other mammals, and tachyzoites multiply and enter into all host nucleated cells, creating the 
parasitophorous vacuole (PV), a highly specialized non-fusogenic compartment [Martin et al., 
2007] delimited by a membrane that allows the passage of small molecules [Gail et al., 2004]. 
After the parasite undergoes repeated replication rounds, the host cells lyse and tachyzoites 
are disseminated via the blood and lymph. When the host immune system becomes activated 
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due to the presence of the parasite, immune cells such as macrophages and lymphocytes 
respond with proliferation, activation, and the release of diverse cytokines including IFN-γ. 
The presence of IFN-γ induces tachyzoite differentiation in bradyzoites and modification of 
the infected host cell in tissue cysts, in which this form of the parasite remains in latency for 
several years, giving rise to chronic infections [Dimier and Bout, 1998]. 
Role of iron in cell invasion by T. gondii  
Iron is an essential component in the intracellular survival and multiplication of T. gondii. 
Obtaining iron from the invaded host cell is a key process that Toxoplasma has to regulate to 
secure an adequate provision at the intravacuolar level. As a strategy, the parasite activates 
the increase of iron regulator proteins (IRPs), which apparently function to stabilize the TFR 
mRNA of host cells; therefore, a high expression of TFR is induced at the membrane in the 
invaded cells, leading to TF-iron capture, which is taken up by intracellular tachyzoites to 
aid in proliferation (Fig. 7). This positive regulation seems to be mediated by soluble factors 
secreted by Toxoplasma that are not yet identified [Gail et al., 2004]. As occurs with other 
parasites, iron chelating agents such as deferoxamine can limit tachyzoite development. This 
effect is reverted through the addition of exogenous holo-TF or ferrous sulfate as sources of 
Fe, conditions that allow successful intracellular replication of the parasite and demonstrate 
the importance of iron in the intracellular development of this parasite [Dimier and Bout, 
1998; Mahmoud, 1999].  
 
Figure 7. Iron uptake by intracellular Toxoplasma gondii. T. gondii lives inside a parasitophorous vacuole 
(PV) within the host cell; from there, it sequesters iron  and depletes the macrophage labile-iron pool 
(LIP), activating the host cytosolic iron-responsive element sensor proteins (IRPs). These proteins 
increase the stability of the TFR mRNA , increasing host cell iron uptake from TF . This positive 
regulation system increases the intracellular iron that the parasite requires for survival. Iron uptake by 
the parasite is limited by TNFγ through an unknown mechanism. 
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In addition to the participation of macrophages and neutrophils in the immune response to 
Toxoplasma, fibroblasts, endothelia, and intestinal cells might also protect against this 
pathogen, most likely through a mechanism that involves the incorporation of iron from 
plasma TF, consequently limiting the availability of Fe resources to the parasite. An 
alternative strategy is the participation of exogenous IFN-γ in the inhibition of intracellular 
tachyzoite replication, a phenomenon observed in a dose-dependent manner in primary 
cultures of rat enterocytes. Interestingly, the exogenous addition of ferrous sulfate or holo-
TF neutralizes entirely the effect of IFN-γ on the enterocytes. Although the precise 
molecular events initiated in enterocytes as a result of IFN-γ exposure are not clear, it has 
been suggested that IFN-γ inhibits tachyzoite replication by a mechanism that involves the 
limitation of available intracellular Fe (Fig. 7) [Dimier and Bout, 1998]. 
Dziadek et al. reported in [2005] that T. gondii tachyzoites of the BK strain bind to human 
holoLF but not holoTF, suggesting the presence of specific membrane receptors of 
Toxoplasma to host mucosal LF. Tanaka studied the expression of Lbps on tachyzoites of the 
RH-strain maintained through Vero cells incubated with labeled bovine LF and bovine TF. 
Both iron-carrier proteins were recognized by a single protein of 42 kDa, suggesting a non-
specific binding to a common receptor [Tanaka et al., 2003]. In additional studies, it was 
determined that both the absence and the excess of Fe produce an inhibition of the 
intracellular proliferation of RH-strain tachyzoites grown in cultured host cells, however, 
the mechanism of action by which this phenomenon occurs is unknown [Tanaka et al., 1997].  
3. Concluding remarks 
Our knowledge of iron-uptake mechanisms from host TF by parasitic protozoa has 
improved in the past few years. These new insights have demonstrated the importance of 
effective iron uptake for virulence and increased the understanding of several mechanisms. 
Although substantial progress has been made, there is surprisingly little information 
available, including information about T. brucei and T. cruzi, which have been extensively 
studied, present interesting differences in their iron internalization mechanisms, and have 
enormous therapeutic potential. In other pathogens with serious medical implications as 
Leishmania, P. falciparum and E. histolytica, there is very limited information available, 
although the importance of iron for their survival is evident.  
It is necessary to obtain more knowledge on the iron acquisition mechanisms in unicellular 
eukaryotic pathogens in order to develop new chemotherapeutic strategies that avoid the 
utilization of host iron by these parasitic organisms that have intense iron requirements. 
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